BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 7, 2005
View Archived Issues
New agents for metabolic diseases reported in recent patents
Read More
Novel compounds for treatment of glaucoma disclosed in patent literature
Read More
Update on sodium oxybate in narcolepsy
Read More
Anti-PDGF-D antibody ameliorates mesangioproliferative glomerulonephritis
Read More
Therapeutic benefits of Oral-lyn insulin spray in diabetes
Read More
Tiagabine improves sleep parameters in patients with primary insomnia
Read More
Prous Science announces publication of a comprehensive review on cachexia
Read More
NBI-12i: MC4-R antagonist studied for cachexia treatment
Read More
Plavix commercial rights transferred in Japan
Read More
Second phase III study for GVAX vaccine for prostate cancer
Read More
Positive phase I results for VP-025
Read More
Preliminary results of phase I study of CRX-675 for ragweed allergy
Read More
Novartis again extends tender offer for Eon Labs
Read More
New phase I study of satraplatin with Taxotere in solid tumors
Read More
Phase I study commences for intranasal parathyroid hormone
Read More
New clinical program for intravitreal VEGF Trap for eye diseases
Read More
Neumune cleared for U.S. human studies
Read More
New indication approved in U.K. for Arimidex
Read More
Biotest and Boehringer Ingelheim to investigate BT-061 for asthma
Read More
IND approval for cell cycle inhibitor AT-7519
Read More
Eyetech selects preclinical candidate in Archemix collaboration
Read More
Enhanced clinical benefits of galiximab plus rituximab in follicular non-Hodgkin's lymphoma
Read More
Therapeutic benefits of rimonabant in prediabetes and obesity
Read More
Megace ES approved for anorexia, cachexia or weight loss in AIDS patients
Read More
New MetroGel product approved for rosacea
Read More
Orphan drug designations for annamycin in ALL, AML
Read More
CB1 receptor antagonist shows promise for osteoporosis treatment
Read More
Well-known antifungal drug analyzed for cancer treatment
Read More
